In contrast to the high prevalence of expression observed in primary B-cell lymphoma samples, SAIL expression in cancer cell lines was found to be mostly restricted to lines of the myeloid lineage. Here, C16orf54 is linked to B-cell non-Hodgkin lymphoma.